Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of mycrobacterial vaccines in CD4+ or CD8+ lymphocyte-deficient mammals

Use of mycrobacterial vaccines in CD4+ or CD8+ lymphocyte-deficient mammals

US Patent 8084041 · Granted Dec 27, 2011

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Monoclonal antibodies for prevention and treatment of herpes simplex viral infec2025
HSV-2-delta-gD vaccines and methods for their production and use2024
Double auxotrophic mycobacterium and uses thereof2024
Attb cell line, transgenic cell lines derived therefrom, and methods of making t2024
Double auxotrophic Mycobacterium and uses thereof2023
Recombinant herpes simplex virus 2 (HSV-2) vaccine vectors2021
Passive transfer of immunity using recombinant herpes simplex virus 2 (HSV-2) va2021
Recombinant herpes simplex virus 2 (HSV-2) vaccine vectors2020
Assays and methods for detecting mycobacterial infections2020
Recombinant herpes simplex virus 2 (HSV-2) vaccine vectors2019
Recombinant herpes simplex virus 2 (HSV-2) vaccine vectors2018
Recombinant herpes simplex virus 2 (HSV-2) vaccine vectors2018